Global and China Hemodialysis Industry Report, 2012-2013
  • Feb/2013
  • Hard Copy
  • USD $2,300
  • Pages:91
  • Single User License
    (PDF Unprintable)       
  • USD $2,200
  • Code: HK028
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,400
  • Hard Copy + Single User License
  • USD $2,500
Hemodialysis is also regarded as artificial kidney, a kind of blood purification targeting mainly at the treatment of renal failure patients. In 2011, the global dialysis population hit 2.158 million, a year-on-year increase of 6.4%. And the growth rate is estimated to maintain around 6% in the upcoming years, with the targeted figure by 2020 soaring to roughly 3.8 million.

Kidney Dialysis Population Worldwide, 1990-2020E

In 2011, the dialysis population concentrated in Europe, Americas and other developed regions. However, with the widening coverage of medical insurance in developing countries as well as increasing national income, the dialysis population in China, India, Brazil and other developing countries are on the rapid rise, with the growth rate more than 10%.

The global hemodialysis market consists of hemodialysis service and hemodialysis equipment. In particular, the hemodialsysis service market embraces larger size, making up 85% or so.

In 2011, the global hemodialysis service market size approximated USD62.5 billion. In Europe, the hemodialysis service is widely offered by public institutions; while hemodialysis service market is dominated by privately-run organizations in the US and Japan. At present, companies offering hemodialysis service worldwide include Fresenius Medical Care,DaVita,etc, and both of Fresenius and DaVita have catered to roughly 370,000 patients all together in 2011.

Global hemodialysis equipment market characterizes high concentration, with European, American and Japanese enterprises as leading players. In 2011, the world’s top 3 hemodialsis equipment producers covered Germany-based Fresenius Medical Care, America-based Baxter International and Sweden-based Gambro. Among the three, Fresenius Medical Care is not only the world’s largest manufacturer of hemodialysis equipment, but also the largest hemodialysis service provider catering to over 233,000 renal patients. In addition, Baxter International is the biggest peritoneal dialysis equipment maker in the world.

In 2012, there were approximately two million end-stage renal disease patients in China. However, since the medicare reimbursement ratio in China was relatively low, only 10% sufferers could afford to receive hemodialysis treatment. With the health insurance coverage widening in phases, the ratio is expected to see big surge in the future.? ?

China is heavily reliant on the import of hemodilysis equipments, with the market occupancy of the imported from Fresenius Medical Care, Gambro and so forth approximating 75% in 2012. There is a small number of homegrown hemodialysis equipment producers in China. A few of hemodialysis machine makers include Guangzhou Jihua Medical Apparatus and Instruments, Chongqing Duotai and Chongqing Shanwaishan Science and Technology, while dialyzer producers comprise Shandong Weigao Group Medical Polymer Company Limited, Jiangsu Lengthen Life Science and Technology, etc.

Given the huge potential in Chinese hemodialysis market, several listed companies have tapped into the field, including Huaren Pharmaceutical Co., Ltd, Guangdong Biolight Meditech and Sichuan Kelun Pharmaceutical Co., Ltd. In particular, Huaren Pharmaceutical Co., Ltd introduced its peritoneal dialysis products in the market in a large scale in 2012Q3; Guangdong Biolight Meditech took over Tianjin Ever -Trust Medical Equipment Development to access into hemodialysis consumable field, and purchased Chongqing Duotai to gain blood dialysis machine & medical instrument registration certificate; and Sichuan Kelun Pharmaceutical Co., Ltd projected more capital to Chengdu Qingshan Likang Pharmaceutical and set foot in peritoneal dialysis field.

The report highlights the followings:

20120114.gif Global hemodialysis population and distribution;
20120114.gif current development, competition pattern and development tendency of global??? hemodialysis equipment and service market;
20120114.gif market scale, competitive landscape, import & export and development prediction of Chinese hemodialysis industry;
20120114.gif Global and China hemodialysis equipment market segments and competition pattern;
20120114.gif Operational analysis, hemodialysis business and development forecast of global and China’s 17 industrial players.

1 Overview of Hemodialysis Industry
1.1 Definition
1.2 Hemodialysis Device
1.3 Hemodialysis Service
1.3.1 In-center Hemodialysis
1.3.2 Home Hemodialysis
1.4 Industry Chain

2 Global Hemodialysis Market
2.1 Dialysis Population
2.2 Market Overview
2.3 Hemodialysis Device Market
2.4 Hemodialysis Service Market
2.5 Dialysis Cost
2.6 Development Tendency

3 Chinese Hemodialysis Market
3.1 Status Quo
3.2 Policy Environment
3.3 Competition Pattern
3.4 Market Size
3.5 Development Trend
3.5.1 Increased Population Accepting Hemodialysis Therapy
3.5.2 Stable Improvement in Dialysis Treatment Ratio

4 Import and Export of Hemodialysis Device in China
4.1 Import
4.2 Export

5 Hemodialysis Market Segments
5.1 Dialysis Machines
5.2 Peritoneal Dialysis Machines
5.3 Dialyzers
5.4 Bloodlines
5.5 Hemodialysis Concentrates, Dialysate
5.6 Hemodialysis Machine for Family Use
5.7 Membrane for Hemodialysis

6 Foreign Manufacturers
6.1 Fresenius Medical Care
6.1.1 Profile
6.1.2 Operation
6.1.3 Dialysis Device Business
6.1.4 Dialysis Service Business
6.1.5 Dialysis Population
6.1.6 Development
6.1.7 Operation in China
6.2 Nikkiso
6.2.1 Profile
6.2.2 Operation
6.2.3 Hemodialysis Business
6.2.4 Operation in China
6.3 Baxter International
6.3.1 Profile
6.3.2 Operation
6.3.3 Hemodialysis Business
6.3.4 Development
6.3.5 Operation in China
6.4 Gambro
6.4.1 Profile
6.4.2 Operation
6.4.3 Development
6.4.4 Operation in China
6.5 Asahi Kasei Corporation
6.5.1 Profile
6.5.2 Operation of Health & Medical Division
6.5.3 Asahi Kasei Medical
6.5.4 Operation in China
6.6 Nipro
6.6.1 Profile
6.6.2 Operation in China
6.7 B. Braun
6.7.1 Profile
6.7.2 Operation
6.7.3 Hemodialysis Business
6.7.4 Operation in China
6.8 Nxstage
6.8.1 Profile
6.8.2 Operation
6.8.3 Portable Hemodialysis Machine Business
6.8.4 Hemodialysis Consumerable Business

7 Major Chinese Manufacturers
7.1 Shandong Weigao Group Medical Polymer Company Limited
7.1.1 Profile
7.1.2 Operation
7.1.3 Revenue Structure
7.1.4 R&D
7.1.5 Hemodialysis Business
7.1.6 Hemodialysis Related Subsidiaries
7.1.7 Development Prospect and Forecast
7.2 Huaren Pharmaceutical Co., Ltd
7.2.1 Profile
7.2.2 Operation
7.2.3 Hemodialysis Business
7.3 Guangdong Biolight Meditech Co., Ltd
7.3.2 Operation
7.3.3 Hemodialysis Business
7.4 Sichuan Kelun Pharmaceutical Co., Ltd
7.4.1 Profile
7.4.2 Operation
7.4.3 Hemodialysis Business
7.5 Guangzhou Jihua Medical Apparatus and Instruments
7.5.1 Profile
7.5.2 Hemodialysis Business
7.6 Bain Medical Equipment (Guangzhou)
7.6.1 Profile
7.6.2 Operation
7.6.3 Hemodialysis Business
7.7 Beijing United Jie Ran Bio-Tech
7.7.1 Profile
7.7.2 Operation
7.8Jiangsu Lengthen Life Science and Technology
7.8.1 Profile
7.8.2 Operation
7.8.3 Hemodialysis Business
7.9 Guangzhou Koncen BioScience
7.9.1 Profile
7.9.2 Operation
Advantage and Disadvantage of In-center Hemodialysis
Advantage and Disadvantage of Home Hemodialysis
Hemodialysis Industry Chain
Global Renal Dialysis Population, 1990-2020E
Number of Patients Accepting Dialysis Therapy Worldwide, 2010-2011
Geographical Distribution of Patients Accepting Dialysis Therapy Worldwide, 2010-2011
Distribution of Patients Accepting Dialysis Therapy by Country Worldwide, 2010-2011
Competition Pattern of Global Hemodialysis Device Market, 2011
Competition Pattern of Global Hemodialysis Machine Market, 2011
Competition Pattern of Global Peritoneal Dialysis Machine Market, 2011
Number of Patients with End-stage Renal Disease (ESRD) Worldwide by Therapy, 2010-2011
Proportion of End-stage Renal Disease (ESRD) Patients by Therapy, 2010-2011
Service Forms of Global Dialysis Industry by Region, 2011
Service Forms of Global Dialysis Industry in Major Countries and Regions, 2011
Dialysis Population of World’s Top 5 Providers of Dialysis Service, 2011
Key Hemodialysis Service Providers and Their Dialysis Patients by Region, 2011
Per Capita Dialysis Cost of Some Countries, 2010
Trade Deficit of Hemodialysis Device in China, 2008-2012
Market Share of Domestic Manufacturers and Foreign Manufacturers in Hemodialysis Market by Sales Value, 2012
Leading Manufacturers with Registration Certificates for Hemodialysis Machine and Medical Instrument and Their Products in China, 2012
Distribution of Hemodialysis Device Manufacturers by Region, 2012
Market Size of Hemodialysis in China, 2012
Positive Correlation between ESRD Patients/Million Population and Per Capita GDP
Import Value and YoY Growth Rate of Hemodialysis Device in China, 2008-2012
Import Volume and YoY Growth Rate of Hemodialysis Device in China, 2008-2012
Import Origin of Hemodialysis Device of China by Value, 2010-2012
Average Unit Import Price of China’s Hemodialysis Device by Country, 2010-2012
Average Price of Import Hemodialysis Device of China by Origin, 2010-2012
Import Value and Proportion of Hemodialysis Device in China by Province/City, 2011-2012
Export Value and YoY Growth Rate of Hemodialysis Device in China, 2008-2012
Export Destination of Hemodialysis Device of China by Value, 2012
Export Value and Proportion of Hemodialysis Device in China by Province/City, 2012
Prices of Common Home-made and Import Dialysers, 2011
Latest Small-Sized Hemodialysis Machines
Five Branches of Fresenius Group
Net Revenue and Operating Income of Fresenius Medical Care, 2008-2012
Net Revenue Structure of Fresenius Medical Care by Product, 2010-2012
Net Revenue Structure of Fresenius Medical Care by Region, 2009-2011
Net Revenue and YoY Growth Rate of Dialysis Products of Fresenius Medical Care, 2008-2012
Net Revenue Structure of Dialysis Products of Fresenius Medical Care by Region, 2009-2011
Revenue and YoY Growth Rate of Dialysis Services of Fresenius Medical Care, 2008-2012
Net Revenue Structure of Dialysis Services of Fresenius Medical Care by Region, 2009-2011
Dialysis Therapy Population and YoY Growth Rate of Fresenius Medical Care, 2008-2012
Proportion of Patients Accepting Dialysis Therapy of Fresenius Medical Care by Region, 2009-2011
Share (by Number of Dialysis Patients) of Fresenius Medical Care in World’s Major Markets, 2011
Production Plants and Key Products of Fresenius Medical Care, 2011
Operation of Chineses Subsidiaries of Fresenius Medical Care, 2011
Business Divisions and Main Businesses of Nikkiso, 2012
Net Sales and Net Income of Nikkiso, FY2009-FY2013
Net Sales Structure of Nikkiso by Division, FY2012
Net Sales Structure of Nikkiso by Region, FY2012
Nikkiso’s Plants Involved in Hemodialysis Business, 2012
Net Sales and YoY Growth Rate of Medical Sector under Nikkiso, FY2008-FY2012
Main Businesses and Products of Baxter
Net Sales and Net Income of Baxter, 2008-2012
Net Sales Structure of Baxter by Division, 2010-2012
Net Sales Structure of Baxter by Region, 2010-2012
Net Sales Structure of Baxter’s Pharmaceutical Product Division by Product, 2010-2012
Net Sales and YoY Growth Rate of Baxter’s Renal Business, 2008-2012
Net Sales Structure of Baxter’s Renal Business by Region, 2010-2012
Net Sales of Baxter from PD and HD Businesses, 2008-2010
Plants and Main Operations of Baxter in China, 2012
EBITDA Net Sales and EBITDA of Gambro, 2008-2012
Company Framework of Asahi Kasei Corporation
Nine Operating Companies of Asahi Kasei Corporation and Their Main Businesses
Net Sales Structure of Asahi Kasei by Division, FY2012
Net Sales and Operating Income of Health Care Division of Asahi Kasei Corporation, FY2008-FY2012
Major Associate Companies of Asahi Kasei Medical
Operating Revenue and Operating Income of Asahi Kasei Medical (Hangzhou), 2007-2009
Hemodialysis Products of Nipro (Shanghai)
Operating Revenue and Total Profit of Nipro (Shanghai), 2007-2009
Four Business Divisions of B. Braun and Their Major Businesses
Sales and EBITDA of B.Braun, 2007-2011
Sales Structure of B. Braun by Division, 2009-2011
Sales Structure of B. Braun by Region, 2009-2011
Revenue Structure of B.Braun from Products and Services, 2009-2011
Revenue and YoY Growth Rate of B.Braun Avitum, 2007-2011
Subsidiaries and Main Businesses of B.Braun in Mainland China, 2011
Revenue of B.Braun Avitum (Shanghai), 2009-2011
Main Business Divisions of NxStage and Their Major Businesses
Revenue and Gross Profit of NxStage, 2008-2012
Revenue Structure of NxStage by Division, 2009-2012
Revenue and Gross Profit of Nxstage’s Portable Dialysis Machine Division, 2008-2012
Revenue Structure of Nxstage’s Portable Dialysis Machine Division by Business, 2008-2012
Nxstage’s Revenue and Gross Profit from Hemodialysis Consumerables, 2008-2012
Product Series of Weigao Group
Revenue and Net Income of Weigao Group, 2008-2012
Revenue Breakdown of Weigao Group by Product, 2010-2012
Revenue Structure of Weigao Group by Product, 2010-2012
Revenue Breakdown of Weigao Group by Region, 2010-2012
Revenue Structure of Weigao Group by Region, 2010-2012
R&D Costs and % of Total Revenue of Weigao Group, 2010-2012
Revenue and Profit of Weigao Group from Blood Purification Products, 2010-2012
Revenue Structure of Weigao Group from Blood Purification Products, 2010-2012
Blood Dialyzer Output of Weigao Group, 2009-2012
Hemodialysis Business Related Subsidiaries of Weigao Group, 2012
Revenue and Net Income of Weigao Group, 2010-2014E
Revenue and Net Income of Huaren Pharmaceutical, 2008-2012
Peritoneal Dialysis Solution Business Development Forecast, 2013-2015
Revenue and Net Income of Guangdong Biolight Meditech, 2008-2012
Revenue and Net Income of Sichuan Kelun Pharmaceutical, 2008-2012
Hemodialysis Product Series of Guangzhou Jihua Medical Apparatus and Instruments
Operating Revenue, Total Profit and Gross Margin of Bain Medical Equipment (Guangzhou), 2008-2009
Operating Revenue, Total Profit and Gross Margin of Beijing United Jie Ran Bio-Tech, 2007-2009
Operating Revenue, Total Profit and Gross Margin ofJiangsu Lengthen Life Science and Technology, 2007-2009
Product Series of Guangzhou Koncen BioScience
Operating Revenue, Total Profit and Gross Margin of Guangzhou Koncen BioScience, 2007-2009

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号